“More Days Than Not”: Cyclothymic Disorder, Explained

Cyclothymic disorder is a pattern, not a bad month. The diagnosis describes at least two years in which mood and energy keep shifting between periods of low-grade elevation and periods of low-grade depression. The shifts are present more days than not, and no symptom-free stretch lasts longer than two months. None of those periods reaches a full hypomanic, manic, or major depressive episode. If one ever does, the diagnosis changes.1

“Mild” is the word most often attached to it, and it misleads. The individual swings are milder than the episodes that define bipolar I and II. The pattern is not mild. It is chronic, it starts early, it is hard for the person and the people around them to predict, and it is often mislabeled for years as personality, moodiness, anxiety, or a depression that never quite responds.34 This essay explains what the diagnosis requires, how it differs from the other bipolar diagnoses, what can look like it, and which treatments have evidence behind them.

Key takeaways

• Cyclothymic disorder is a two-year pattern of subthreshold highs and lows, present more days than not, with no full episode ever; it is diagnosed from the history, not from a test or a single visit.
• It sits on the bipolar spectrum, and a meaningful share of people later receive a bipolar I or II diagnosis, but the published percentages come from small or selected samples and are not a forecast for one person.
• The best-supported treatments are structured psychotherapy and a steady daily rhythm; medication is sometimes used, borrowed from bipolar care, and an antidepressant on its own needs particular caution.

Zoom

What the diagnosis actually requires

DSM-5-TR asks for four things. First, at least two years (one year in children and adolescents) with numerous periods of hypomanic symptoms that never met the criteria for a hypomanic episode, and numerous periods of depressive symptoms that never met the criteria for a major depressive episode. Second, those periods were present for at least half of that time, and no symptom-free stretch lasted longer than two months. Third, the criteria for a manic, hypomanic, or major depressive episode have never been met. Fourth, the pattern causes real distress or impairment and is not better explained by a psychotic disorder, a substance, a medicine, or a medical condition.1

ICD-11 describes a similar shape and one real difference. It also asks for persistent mood instability over at least two years, with numerous hypomanic and depressive periods present more of the time than not, depressive symptoms that have never been severe or long enough to meet the requirements for a depressive episode, and no history of a manic or mixed episode. But on the elevated side it is explicitly looser: the hypomanic symptoms may or may not be severe or prolonged enough to meet the full requirements for a hypomanic episode.2 Under DSM-5-TR a full hypomanic episode rules the diagnosis out; under ICD-11 it does not. Both systems describe a long record rather than a snapshot, and a clinician should work from one of them rather than mixing the two.

The word “subthreshold” carries the weight. A hypomanic period in cyclothymia might be three days of less sleep, faster speech, more plans, and more spending, without the four-day duration or the full symptom cluster that a hypomanic episode requires. A depressive period might be a week of low mood, low energy, and withdrawal that never reaches the two-week, five-symptom bar of a major depressive episode. Each stretch stops short of the line. The pattern of stretches, over years, is the diagnosis.

Think of a long ferry crossing in steady chop. There is no storm and no flat calm, but the boat never sits still, and the passengers still arrive worn out. That is all the image is meant to show: a persistent motion that costs something even though no single wave is dramatic. It says nothing about cause, and a person is not a boat.

Under DSM-5-TR, if a full manic, hypomanic, or major depressive episode occurs after the initial two years, the diagnosis changes to the disorder that now fits and cyclothymic disorder is no longer recorded.1 ICD-11 draws that line differently on the elevated side, as above. A change in diagnosis is a change in the evidence, not a failure of the earlier assessment.

How it differs from bipolar I and II

The bipolar I versus bipolar II essay explains why the type names which episodes have occurred rather than how much the illness costs. The same rule applies here. Cyclothymic disorder names a pattern. It does not measure burden, and studies of people who carry the diagnosis find impairment in work, relationships, and daily function that is not small.34

How common it is, and why the number is argued about

DSM-5-TR gives a lifetime prevalence of 0.4 to 1 percent in the general population, and says it may range from 3 to 5 percent in mood-disorder clinics.1 For comparison, national survey data cited by NIMH estimate that 2.8 percent of U.S. adults had some form of bipolar disorder in the past year and 4.4 percent at some point in life. Those figures rest on interviews conducted from 2001 to 2003 and do not separate cyclothymic disorder from the other types.5

Some clinical researchers argue that the DSM definition is too narrow. Perugi and colleagues describe cyclothymia as an exaggeration of a lifelong temperament, marked by mood reactivity, interpersonal sensitivity, and frequent mixed states, and they report that a large share of people seeking help for mood, anxiety, and impulse problems fit that broader description.46 A 2012 critical review reached a related conclusion: cyclothymic disorder may be the most prevalent form of bipolar disorder and is rarely diagnosed in practice.3

Those two pictures use different definitions, so their numbers should not be compared as if they measured the same thing. The practical lesson is narrower and more useful. A person who has felt unstable for years, and has been given several different labels, deserves an assessment that asks specifically about the pattern over time.

What the course can look like

The oldest prospective study is still informative. Akiskal and colleagues identified 46 cyclothymic outpatients from a pool of 500, followed them for two to three years, and compared them with people who had classic bipolar disorder and people with personality disorders. Two-thirds had previously been diagnosed with hysteria or sociopathy, that is, with character rather than mood. During drug-free follow-up, 35 percent developed a full hypomanic, manic, or depressive episode, and 44 percent had brief hypomanic reactions while taking a tricyclic antidepressant.7 The sample was small, drawn from one clinic in the 1970s, and the drugs have changed since. The direction of the finding has held up.

A more recent study followed 201 college-age adults with early-onset “soft” bipolar spectrum conditions for four and a half years. Of the 57 who started with cyclothymia or bipolar disorder not otherwise specified, 42.1 percent progressed to a bipolar II diagnosis and 10.5 percent to bipolar I.8 Those participants were recruited by questionnaire from a university population, not from a clinic, and the two starting diagnoses were pooled, so the figure is not a clean cyclothymia-only rate.

DSM-5-TR summarizes the literature as a 15 to 50 percent risk of eventually developing bipolar I or II.1 That range is wide because the studies differ in who was enrolled, how long they were followed, and what counted as progression. It is a reason to keep an eye on the pattern. It is not a coin a reader can flip for their own future, and many people stay in the cyclothymic range. Whether the pattern eases with age is genuinely unsettled: DSM-5-TR describes an insidious onset and a persistent course, and the follow-up studies are too few and too different to say how often it lets up.13

Two things the studies do not show are worth naming. They do not show that progression is caused by the person doing something wrong. And they do not show that treatment guarantees it will not happen. What early recognition can do is shorten the years spent with the wrong label and the wrong plan.6

What can look similar

The overlap with borderline personality disorder deserves a plain statement. Perugi, Fornaro, and Akiskal have argued that atypical depression, borderline personality disorder, and bipolar II may be overlapping expressions of the same cyclothymic diathesis.9 Other clinicians hold that the two are distinct conditions that can coexist. A careful assessment describes both what the mood does and how it responds to relationships, rather than choosing a label in the first hour.39

In children and adolescents, the diagnosis is used less often and studied less. A study of 827 young people in an outpatient clinic found 52 who met the criteria. They could be distinguished from non-mood conditions by irritability, sleep disturbance, age of onset, other diagnoses, and family history, and the authors called their analyses exploratory.10 The depression-first essay explains why a lifetime timeline matters in any bipolar assessment. For a young person it should include a parent’s account, with the young person’s consent where possible.

What treatment has evidence

There is no medicine approved by the FDA for cyclothymic disorder, and the major bipolar guidelines write their treatment recommendations for bipolar I and II rather than offering a separate, evidence-graded plan for cyclothymia.11 What exists is a small number of cyclothymia-specific trials, a larger body of bipolar I and II evidence that may or may not transfer, and the clinical experience of a few specialist groups. Care should be honest about which of the three a given recommendation rests on.

Psychotherapy has the clearest cyclothymia-specific trial. Fava and colleagues randomized 62 people with DSM-IV cyclothymic disorder to ten sessions of cognitive behavioral therapy followed by well-being therapy, or to ten sessions of clinical management. The therapy group improved more on both depressive and manic-symptom measures, and the gains held at one- and two-year follow-up.12 It is one trial from one group, and it tested a specific sequence rather than “therapy” in general. It is still the strongest cyclothymia-specific evidence available.

Perugi’s group describes a psychoeducation model built around the temperament rather than the symptom of the week: learning the personal pattern, protecting sleep and daily rhythm, and planning for the periods of elevation as well as the lows.6 That model is expert-derived and has not been tested in a randomized trial. The bipolar therapies with trial support, including interpersonal and social rhythm therapy and group psychoeducation, were tested in people with bipolar disorder rather than cyclothymic disorder, so their benefit here is inferred rather than shown.13 The therapy essay explains what each of those approaches involves.

Medication is borrowed from bipolar care, and the borrowing should stay visible. Clinicians sometimes use the bipolar mood stabilizers when the instability is impairing and therapy alone has not been enough. The cyclothymia-specific evidence is thin: small older studies, open-label reports, and the specialist groups’ experience.36 The mood stabilizers essay explains what each medicine asks of the person taking it, including lithium levels and lamotrigine’s rash rule. Those rules do not relax because the diagnosis is cyclothymia. Valproate deserves its own sentence, because cyclothymia usually starts young: it carries the strongest reproductive warnings of the group, including major congenital malformations and neurodevelopmental effects after pregnancy exposure, and for anyone who could become pregnant another option is usually preferred. Raise it before it is prescribed, not after.

An antidepressant alone needs particular caution. In the 1977 cohort, 44 percent of the people in it had brief hypomanic reactions on a tricyclic.7 The ISBD antidepressant task force advised caution and found the evidence limited, with attention to any past activation and to mixed symptoms. That report was written for bipolar I and II and does not address cyclothymic disorder, so it is a reason for care here rather than a recommendation about it.14 The antidepressant essay explains what “feeling wired” can mean and what to report. None of this means a person with cyclothymia can never take one. It means the decision should be made with the pattern in view.

Whatever the plan, a steady sleep and activity rhythm is the part of care with the fewest side effects. The sleep essay explains how to notice a change from your own baseline without turning every short night into an alarm.

What to bring to an evaluation

A cyclothymia assessment is a history-taking exercise. Best estimates are enough. Bring:

• when the ups and downs began, as best you can place it, and whether there has ever been a stretch of two months or more that felt level;
• what an “up” looks like for you: sleep need, speech, spending, plans, irritability, and how long it lasts;
• what a “down” looks like, and how long it lasts;
• whether any period was ever bad enough to stop work or school, involve a hospital, or include psychosis;
• past diagnoses and what happened on each treatment, especially any antidepressant;
• alcohol, cannabis, stimulants, and prescribed medicines, with timing;
• family history of mood disorders; and
• what a trusted person has noticed, if you want that included.

A two-week daily mood and sleep log, kept on paper or in a phone note, can make the pattern visible in a way memory cannot. It is a visit-preparation tool. It is not a diagnostic instrument, and it cannot tell you which diagnosis fits.

Hypothetical conversation: “I have been told I am moody, then anxious, then depressed. What I notice is that I am rarely level for long. A few days I sleep less and start things; then for a week or two I can barely answer messages. It has been like this since my late teens. Can we look at the whole pattern instead of just this month?”

When to seek help sooner

Routine assessment fits a long-standing pattern without a current dangerous change. Prompt, same-day contact is warranted for a new stretch of much less sleep with rising energy and changed judgment, for hopelessness that is deepening, or for a marked change after a medicine is started or stopped. A period that is now longer, higher, or lower than anything before may mean the diagnosis has changed, and that needs assessment rather than a label from a website.

Immediate danger calls for emergency help. Call 911 for imminent self-harm danger, severe confusion, psychosis with unsafe behavior, or inability to stay safe. Call or text 988 (the Suicide & Crisis Lifeline) when you need help deciding what to do next.15 Do not wait for symptoms to reach a diagnostic threshold before asking for help. In this condition they may never reach one, and that has no bearing on whether you are safe today. Thoughts of death during a low stretch are part of the illness for some people and deserve the same seriousness they would in any other diagnosis.

This week, if the pattern sounds familiar, start a two-week sleep and mood log and book a bipolar-care evaluation that asks about the whole history.

Frequently asked questions

Is cyclothymic disorder a real diagnosis or just a moody personality?

It is a diagnosis in both DSM-5-TR and ICD-11, defined by a two-year pattern of subthreshold highs and lows that cause distress or impairment. Researchers do debate where temperament ends and disorder begins, and some argue the two are points on one continuum. In practice, a pattern that is costing you work, relationships, or peace of mind deserves assessment whichever word is used.

Will it turn into bipolar I or II?

It can. Published estimates run from 15 to 50 percent, and one small older cohort found that 35 percent developed a full episode within two to three years. The ranges are wide because the studies differ, and none of them can forecast one person. Many people stay in the cyclothymic range. A new stretch that is longer or more severe than anything before is a reason to be reassessed.

Do I need medication?

Not necessarily. The clearest cyclothymia-specific trial evidence is for structured psychotherapy, and a steady sleep and daily rhythm helps many people. Medicines used in bipolar disorder are sometimes added when instability is impairing, but the cyclothymia-specific evidence is thin, and each medicine carries its own monitoring and safety rules. That decision belongs with a prescriber who knows your full history.

Can I take an antidepressant?

Sometimes, with care. The concern is activation or a switch into a hypomanic stretch, which was common in the oldest cyclothymia cohort on tricyclics. A prescriber will weigh past reactions, mixed symptoms, and what else is in the plan. Do not start, stop, or change one on your own, and report a wired feeling promptly.

How is it different from borderline personality disorder?

Borderline mood shifts tend to be faster, often minutes to hours, and tied to relationships, with chronic emptiness and identity disturbance. Cyclothymic periods tend to last days to weeks and arise more on their own. Some researchers see a shared underlying vulnerability, and the two can coexist. A careful assessment looks at both the mood pattern and the relational pattern.

What should prompt help today?

A stretch that is longer, higher, or lower than anything you have had before, hopelessness that is deepening, severe new restlessness after a medicine change, or a marked change in sleep need all deserve prompt contact, often the same day. Immediate danger, psychosis, or being unable to stay safe needs emergency help. Do not wait to meet a duration rule, and do not wait for a diagnosis.

How is it diagnosed without a test?

From the history: at least two years of numerous subthreshold highs and lows, present more days than not, no symptom-free stretch beyond two months, and never a full episode. A clinician also reviews substances, medicines, medical causes, family history, and what others have observed. A mood log and a timeline help. A questionnaire score does not settle it.

This article is for education, not personal medical advice. Do not start, stop, restart, or change a medication without the clinician who manages it. Every PubMed citation, crisis number, and internal link in this article was verified against its primary source on September 25, 2026. Guidelines, drug labels, and public-health data change; confirm current status before acting on anything here.

Related reading on NP FADY

• “The Shout and the Hum”: Bipolar I vs. Bipolar II
• “You Only Photograph the Low Tide”: Why It Gets Called Depression First
• Fast and Heavy at the Same Time
• “A Sail Without a Keel”: When an Antidepressant Alone Can Make Things Worse
• “The Shop Sets the Humidity Before It Cuts the Wood”: Why Sleep Changes Often Matter Early in Bipolar Disorder
• I Thought This Was Just My Personality: Persistent Depressive Disorder, Explained

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). APA Publishing; 2022. Cyclothymic disorder criteria, prevalence, and course. DOI: 10.1176/appi.books.9780890425787. Publisher record checked September 25, 2026; diagnostic chapter subscription-restricted.

2. World Health Organization. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (CDDR). WHO; 2024. Cyclothymic disorder (6A62). Official publication. Accessed September 25, 2026.

3. Van Meter AR, Youngstrom EA, Findling RL. Cyclothymic disorder: a critical review. Clinical Psychology Review. 2012;32(4):229–243. doi:10.1016/j.cpr.2012.02.001. Original abstract.

4. Perugi G, Hantouche E, Vannucchi G, Pinto O. Cyclothymia reloaded: a reappraisal of the most misconceived affective disorder. Journal of Affective Disorders. 2015;183:119–133. doi:10.1016/j.jad.2015.05.004. Original abstract.

5. National Institute of Mental Health. Bipolar disorder: statistics. Official page. Accessed September 25, 2026.

6. Perugi G, Hantouche E, Vannucchi G. Diagnosis and treatment of cyclothymia: the “primacy” of temperament. Current Neuropharmacology. 2017;15(3):372–379. doi:10.2174/1570159X14666160616120157. Full text.

7. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. American Journal of Psychiatry. 1977;134(11):1227–1233. doi:10.1176/ajp.134.11.1227. Original abstract.

8. Alloy LB, Urošević S, Abramson LY, et al. Progression along the bipolar spectrum: a longitudinal study of predictors of conversion from bipolar spectrum conditions to bipolar I and II disorders. Journal of Abnormal Psychology. 2012;121(1):16–27. doi:10.1037/a0023973. Full text.

9. Perugi G, Fornaro M, Akiskal HS. Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? World Psychiatry. 2011;10(1):45–51. doi:10.1002/j.2051-5545.2011.tb00013.x. Original record.

10. Van Meter A, Youngstrom EA, Youngstrom JK, Feeny NC, Findling RL. Examining the validity of cyclothymic disorder in a youth sample. Journal of Affective Disorders. 2011;132(1-2):55–63. doi:10.1016/j.jad.2011.02.004. Full text.

11. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. 2018;20(2):97–170. doi:10.1111/bdi.12609. Full guideline.

12. Fava GA, Rafanelli C, Tomba E, Guidi J, Grandi S. The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder. Psychotherapy and Psychosomatics. 2011;80(3):136–143. doi:10.1159/000321575. Original abstract.

13. Miklowitz DJ, Efthimiou O, Furukawa TA, et al. Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis. JAMA Psychiatry. 2021;78(2):141–150. doi:10.1001/jamapsychiatry.2020.2993. Original abstract.

14. Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. American Journal of Psychiatry. 2013;170(11):1249–1262. doi:10.1176/appi.ajp.2013.13020185. Full text.

15. 988 Suicide & Crisis Lifeline. Get help. Accessed September 25, 2026.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, or chat at 988lifeline.org, available 24/7, free and confidential. En español: marque 988 y oprima 2, o envíe AYUDA al 988. Deaf or hard of hearing: 988 videophone (ASL) or TTY 711 then 988. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.